Symbols

RKDA

Arcadia Biosciences·NASDAQ

--(--)

7.82 / 10

Outperform

Analyst coverage is absent (ana_eval = -1). Fund‑flow scoring is good at 7.82, with block, large and extra‑large investors showing net inflows, though overall trend is negative. Capital flow remains supportive despite mixed sentiment.

Fund Flow Rating

What is the analyst consensus for RKDA?

RKDA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.82/10 (Outperform).